Monopar Therapeutics

MNPRCIK 0001645469 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 1, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0064

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

May 29, 20267.01 · Regulation FD Disclosure9.01 · Financial Statements and Exhibits May 19, 2026no items parsed May 14, 2026no items parsed Apr 20, 2026no items parsed Mar 27, 2026no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Monopar Therapeutics

Name	Roles	Filings
O'Halloran Thomas V.	-	2
Radhakrishnan Karthik	Officer	2
Tactic Pharma LLC	10% Owner	2
Talukdar Lavina	Director	2
Hendricks Diane	10% Owner	1

Showing 11-15 of 17

Per pagePrevPage 3 of 4Next

Top performers

Insiders ranked by realized 90-day signed return on their open-market trades at Monopar Therapeutics. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.

#	Insider	Trades	Win rate	Avg	Median	Best	Worst
1	Robinson Chandler	3	67%	-39.0%	+3.5%	+12.9%	-133.4%
2	Cittadine Andrew	10	20%	-19.6%	-22.5%	+17.1%	-47.5%

All filings

128 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jan 5, 2026	Cittadine Andrew Chief Operating Officer	FTax	1,889	$65.30	$123,352
Jan 5, 2026	Robinson Chandler Chief Executive Officer · Director	FTax	2,558	$65.30	$167,037
Dec 29, 2025	Vu Quan Anh Chief Financial Officer	PPurchase	1,500	$69.95	$104,925
Dec 19, 2025	Klausner Arthur J Director	SSale	4,660	$67.06	$312,500
Dec 17, 2025	Klausner Arthur J Director	JOther	7,710	$0.00	$0

Showing 6-10 of 128

Per pagePrevPage 2 of 26Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value